Panel Discussion – Key Considerations in Gene Therapy Manufacturing for Commercialization – Please Submit Questions
We are excited at Cell Culture Dish to be chairing a panel discussion at next week’s Cell and Gene Therapy Bioprocessing and Commercialization Conference. The panel titled, Key Considerations in Gene Therapy Manufacturing for Commercialization, will focus on gene therapy manufacturing, including the latest in manufacturing methods, analytical analysis and key regulatory considerations. Topics to be discussed include:
- Planning for scale up, technology transfer and regulatory considerations on the way to commercialization.
- In-house vs. Outsourcing manufacturing.
- Ensuring scalability and efficient timelines in manufacturing while still maintaining reasonable cost.
- Analytical Development
- Where are we at as an industry and where is there room for improvement.
Panel members include:
Brandy Sargent – Editor, Cell Culture Dish, USA
Nina Forsberg – Marketing Director, Vironova, Sweden
Clive Glover – Senior Global Marketing Manager, Pall, United Kingdom
John Madsen – Head, Process Development Operations, Fujifilm Diosynth Biotechnologies, USA
Tracy TreDenick – Head of Regulatory and Quality Assurance, Founding Partner, BioTechLogic, USA
Ross Verheul – Senior Application Scientist, Beckman Coulter Life Sciences, USA
Joe Hughes – Chief Scientist, VP Process and Analytical Development, WuXi Advanced Therapies
Pratik Jaluria – Executive Director of the Process Development & Manufacturing Group, Adverum Biotechnologies
Can’t make it in person? In addition to questions from the audience, we would also like to include questions from our readers. We will be publishing an audio recording of the panel as a podcast after the event.
Please submit your questions using the form below, we look forward to hearing from you.